Ads
related to: catalent pharma servicescatalent.com has been visited by 10K+ users in the past month
Search results
Results from the Health.Zone Content Network
Catalent, Inc. ( Catalent Pharma Solutions) is a multinational corporation headquartered in Somerset, New Jersey. It is a global provider of delivery technologies, development, drug manufacturing, biologics, gene therapies and consumer health products. It employs more than 14,000 people, [2] including approximately 2,400 scientists and technicians.
The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S. Federal Trade Commission (FTC) for approval of a $16.5 billion deal to buy manufacturing subcontractor Catalent, a ...
After the deal closes, Novo Holdings will sell three of Catalent's fill-finish sites - in Anagni, Italy; Brussels, Belgium; and Bloomington, Indiana - onto Novo Nordisk for $11 billion.
Novo Nordisk then plans to buy three of Catalent’s manufacturing sites for $11 billion, the company announced in February. For the 2024 outlook, the company said its sales growth is now expected ...
Novo Holdings A/S (formerly Novo A/S) [1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation 's assets, which in 2023 was worth almost DKK 1,114 billion. [2] [3] [4] Danish Kroner (approximately US$163 billion ...
Catalent Inc is close to reaching a settlement with activist investor Elliott Investment Management which will include new directors and a pledge to review strategic alternatives such as a sale of ...
Ads
related to: catalent pharma servicescatalent.com has been visited by 10K+ users in the past month